Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.38B
Enterprise Value2.06B
P/E Ratio41.7
PEG Ratio6.67
Price/Sales Ratio8.77
Price/Book Ratio2.72
Enterprise/Revenue7.16
Enterprise/EBITDA29.47

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.22
Operating Margin0.26
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.07

Income Statement

Revenue265.36M
Revenue/Share1.58
Gross Profit102.86M
EBITDA63.09M
Net Income54.21M
Diluted EPS0.34

Balance Sheet

Total Cash771.53M
Total Cash/Share4.68
Total Debt0
Total Debt/Equity0
Current Ratio16.38
Book Value Per Share5.25

Price History

52-Week Change-16.72
52-Week High18.25
52-Week Low11.53
Moving Average 50 Days13.29
Moving Average 200 Days15.11

Statistics

Average Volume4.92M
Shares Outstanding160M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield2.1
Payout Ratio0.86
Last Split Factor2:1
Last Split DateJuly 04, 2017
AD